These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8139732)

  • 1. Creatol, a creatinine metabolite, as a useful determinant of renal function.
    Nakamura K; Ienaga K; Nakano K; Nakai M; Nakamura Y; Hasegawa G; Sawada M; Kondo M; Mori H; Kanatsuna T
    Nephron; 1994; 66(2):140-6. PubMed ID: 8139732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic renal failure and serum accumulation of the creatinine oxidative metabolites creatol and methylguanidine.
    Nakamura K; Ienaga K; Nakano K; Nakai M; Nakamura Y; Hasegawa G; Sawada M; Kondo M; Mori H; Kanatsuna T
    Nephron; 1996; 73(4):520-5. PubMed ID: 8856245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatol, an oxidative product of creatinine in kidney transplant patients, as a useful determinant of renal function: a preliminary study.
    Matsumoto S; Hanai T; Matsuura T; Uemura H; Nishioka T; Akiyama T
    Transplant Proc; 2006 Sep; 38(7):2009-11. PubMed ID: 16979981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure.
    Ienaga K; Nakamura K; Fujisawa T; Fukunaga Y; Nihei H; Narita M; Tomino Y; Sanaka T; Aoyagi K; Nakano K; Koide H
    Ren Fail; 2007; 29(3):279-83. PubMed ID: 17497440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatol, an oxidative product of creatinine in hemodialysis patients.
    Tomida C; Aoyagi K; Nagase S; Gotoh M; Yamagata K; Takemura K; Koyama A
    Free Radic Res; 2000 Jan; 32(1):85-92. PubMed ID: 10625220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatol and chronic renal failure.
    Ienaga K; Nakamura K; Fukunaga Y; Nakano K; Kanatsuna T
    Kidney Int Suppl; 1994 Nov; 47():S22-4. PubMed ID: 7869666
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily hydroxyl radical scavenging capacity of mammals.
    Ienaga K; Hum Park C; Yokozawa T
    Drug Discov Ther; 2014 Apr; 8(2):71-5. PubMed ID: 24815581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of methylguanidine from creatinine via creatol by active oxygen species: analyses of the catabolism in vitro.
    Nakamura K; Ienaga K; Yokozawa T; Fujitsuka N; Oura H
    Nephron; 1991; 58(1):42-6. PubMed ID: 1649975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum levels of creatol and methylguanidine in renal injury induced by lipid peroxide produced by vitamin E deficiency and GSH depletion in rats.
    Ozasa H; Watanabe T; Nakamura K; Fukunaga Y; Ienaga K; Hagiwara K
    Nephron; 1997; 75(2):224-9. PubMed ID: 9041546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure.
    Niwa T; Aoyama I; Takayama F; Tsukushi S; Miyazaki T; Owada A; Shiigai T
    Miner Electrolyte Metab; 1999; 25(1-2):118-22. PubMed ID: 10207273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of creatinine, creatol and methylguanidine on renal function.
    Yokozawa T; Oura H; Ienaga K; Nakamura K
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):973-7. PubMed ID: 1479734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure.
    Yokozawa T; Oura H; Ienaga K; Nakamura K
    Nephron; 1993; 64(3):424-8. PubMed ID: 8341388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary epidermal growth factor excretion in children with chronic renal failure.
    Tsau Y; Chen C
    Am J Nephrol; 1999; 19(3):400-4. PubMed ID: 10393378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oxidative stress markers for the early diagnosis of allograft rejection in feline renal allotransplant recipients with normal renal function.
    Halling KB; Ellison GW; Armstrong D; Aoyagi K; Detrisac CJ; Graham JP; Newell SP; Martin FG; Van Gilder JM
    Can Vet J; 2004 Oct; 45(10):831-7. PubMed ID: 15532882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hydroxyl radical generation in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
    Osaka M; Aoyagi K; Hirakawa A; Nakajima M; Jikuya T; Shigeta O; Sakakibara Y
    Free Radic Res; 2006 Feb; 40(2):127-33. PubMed ID: 16390821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of acute renal failure and chronic renal failure by 2-dimensional analysis of urinary dipeptidase versus serum creatinine.
    Lee SH; Kang BY; We JS; Park SK; Park HS
    Ren Fail; 1999 Mar; 21(2):169-76. PubMed ID: 10088177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of adenine nucleotides in blood of predialysis patients with chronic renal failure].
    Bułło B; Marlewski M; Manitius J; Smoleński RT; Rutkowski B
    Pol Arch Med Wewn; 1995 Nov; 94(5):389-94. PubMed ID: 8833935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1- methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease.
    Hasegawa G; Nakano K; Ienaga K
    Clin Nephrol; 2011 Oct; 76(4):284-9. PubMed ID: 21955863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients.
    Nakamura K; Ienaga K
    Experientia; 1990 May; 46(5):470-2. PubMed ID: 2347396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.